Literature DB >> 19853554

Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.

Xiao-Cheng Wu1, Patricia Andrews, Vivien W Chen, Frank D Groves.   

Abstract

BACKGROUND: Extranodal non-Hodgkin lymphoma (NHL) accounts for much of the increase in NHL incidence in the past three decades in the United States, but its descriptive epidemiology is scarce in the literature.
METHODS: Incidence data for the years 1999-2003 were from 38 population-based cancer registries, covering 82% of US population. We grouped anatomic sites of extranodal NHLs according to the Surveillance, Epidemiology, and End Results (SEER) site recodes, and histology subtypes according to the nested classification of lymphoid neoplasms developed by the Pathology Working Group of the International Lymphoma Epidemiology Consortium.
RESULTS: Blacks and Asians/Pacific Islanders (APIs) experienced incidence rates about the same as or lower than whites' for B-cell extranodal NHL as a whole and most of its histologic subtypes. The significant exceptions are: API men had a 40% higher rate of marginal zone lymphoma (MZL) than white men, and API women had a 12% higher rate of diffuse large B-cell lymphoma (DLBCL) than white women. The rates of all T-cell extranodal NHLs combined and peripheral T-cell lymphoma (PTCL) among black women exceeded those of white women by 46% and 18%, respectively. Blacks also had higher rates of mycosis fungoides (MF) than whites (28% higher for men and 99% higher for women). The most common sites of extranodal NHL are stomach, skin, and oral cavity and pharynx. Compared with whites, blacks had either lower or similar incidence of NHL for all sites except skin for women while APIs had higher rates of NHL of the stomach, nose/nasal cavity/middle ear, colorectum (women only), and brain (men only). Age was associated with race- and sex-specific differences in histology-specific incidence rates.
CONCLUSION: While blacks and APIs had lower or similar overall incidence rates for extranodal NHL, they experienced excessive rates in some subtypes. Blacks had higher rates of the two most common types of T-cell extranodal NHL and APIs had higher rate of the two common types of B-cell types than whites. Distinct race-specific patterns in histology- and site-specific incidence of extranodal NHL may implicate racial differences in risk factor exposure and/or genetic predisposition.

Entities:  

Mesh:

Year:  2009        PMID: 19853554     DOI: 10.1016/j.canep.2009.09.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  24 in total

1.  Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.

Authors:  Jill Koshiol; Tram Kim Lam; Gloria Gridley; David Check; Linda Morris Brown; Ola Landgren
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

2.  CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection.

Authors:  Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  Primary sino-orbital peripheral T-cell lymphoma presenting as unilateral periorbital swelling: a case report.

Authors:  Ahmad Al Omari; Firas Al Zoubi; Mohammad M Alsalem; Khalil M Al-Salem; Hasan Mohidat
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

4.  Cancers Due to Infection and Selected Environmental Factors.

Authors:  Thomas Gredner; Gundula Behrens; Christian Stock; Hermann Brenner; Ute Mons
Journal:  Dtsch Arztebl Int       Date:  2018-09-03       Impact factor: 5.594

5.  A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.

Authors:  Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

6.  Gastrointestinal lymphoma in Western Algeria: pattern of distribution and histological subtypes (retrospective study).

Authors:  Soumia Zeggai; Noria Harir; Abdenacer Tou; Miloud Medjamia; Khaira Guenaoui
Journal:  J Gastrointest Oncol       Date:  2016-12

7.  Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.

Authors:  Elizabeth K Cahoon; Ruth M Pfeiffer; David C Wheeler; Juan Arhancet; Shih-Wen Lin; Bruce H Alexander; Martha S Linet; D Michal Freedman
Journal:  Int J Cancer       Date:  2014-10-13       Impact factor: 7.396

8.  Delayed diagnosis of sinonasal lymphoma due to bilateral manifestation.

Authors:  Si-Young Kiessling; Michael B Soyka; Gerhard F Huber; David Holzmann; Roman D Laske
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-31       Impact factor: 2.503

9.  Clinically undiagnosed enteropathy associated T-cell lymphoma type II presenting with prolonged lower gastrointestinal tract symptoms: report of an autopsy case and review of diagnostic challenges and clinicopathological correlation.

Authors:  Andrew J Rand; Diana M Cardona; Alan D Proia; Anand S Lagoo
Journal:  J Gastrointest Oncol       Date:  2013-03

10.  Clinicopathological characteristics and prognostic factors of primary gastrointestinal lymphoma: a 22-year experience from South China.

Authors:  Minrui Li; Shenghong Zhang; Fang Gu; Weiwei Xiao; Jiayan Yao; Kang Chao; Minhu Chen; Juan Li; Bihui Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.